Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-05
DOI
10.3389/fneur.2021.814174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the mdx Mouse Model of Duchenne Muscular Dystrophy
- (2021) Rachael A Potter et al. HUMAN GENE THERAPY
- Synthetic Biology: Emerging Concepts to Design and Advance Adeno‐Associated Viral Vectors for Gene Therapy
- (2021) Hanna J. Wagner et al. Advanced Science
- Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
- (2021) Mohammadsharif Tabebordbar et al. CELL
- The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
- (2021) Shelagh M. Szabo et al. Orphanet Journal of Rare Diseases
- Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)
- (2020) Elena Abati et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
- (2020) Helena Costa Verdera et al. MOLECULAR THERAPY
- Broader Implications of Progressive Liver Dysfunction and Lethal Sepsis in Two Boys following Systemic High-Dose AAV
- (2020) Leon Morales et al. MOLECULAR THERAPY
- Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy
- (2020) Jerry R. Mendell et al. JAMA Neurology
- Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice
- (2020) Philippine Aupy et al. Molecular Therapy-Methods & Clinical Development
- After Third Death, Audentes' AT132 Remains on Clinical Hold
- (2020) Alex Philippidis HUMAN GENE THERAPY
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Onasemnogene Abeparvovec: First Global Approval
- (2019) Sheridan M. Hoy DRUGS
- Muscular dystrophies
- (2019) Eugenio Mercuri et al. LANCET
- O.40Intrathecal administration of onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 2 (SMA2): phase 1/2a study (STRONG)
- (2019) R. Finkel et al. NEUROMUSCULAR DISORDERS
- Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
- (2019) Pierce J. Ogden et al. SCIENCE
- Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice
- (2018) Cinzia Pisani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy
- (2018) Dongsheng Duan MOLECULAR THERAPY
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- S/MAR Element Facilitates Episomal Long-Term Persistence of Adeno-Associated Virus Vector Genomes in Proliferating Cells
- (2017) Claudia Hagedorn et al. HUMAN GENE THERAPY
- Long-term effects of systemic gene therapy in a canine model of myotubular myopathy
- (2017) Matthew Elverman et al. MUSCLE & NERVE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
- (2017) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion
- (2017) Longping Victor Tse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
- (2017) Caroline Le Guiner et al. Nature Communications
- Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations
- (2015) Valeria Ricotti et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus
- (2015) Yongping Yue et al. HUMAN MOLECULAR GENETICS
- A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
- (2015) Jerry R Mendell et al. MOLECULAR THERAPY
- Duchenne Muscular Dystrophy: From Diagnosis to Therapy
- (2015) Maria Falzarano et al. MOLECULES
- Immune-mediated pathology in Duchenne muscular dystrophy
- (2015) Amy S. Rosenberg et al. Science Translational Medicine
- Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning
- (2015) Manuela Corti et al. Human Gene Therapy Clinical Development
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates
- (2014) Darren A. Murrey et al. Human Gene Therapy Clinical Development
- Differential Adeno-Associated Virus Serotype-Specific Interaction Patterns with Synthetic Heparins and Other Glycans
- (2013) M. Mietzsch et al. JOURNAL OF VIROLOGY
- Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin α2 Surrogates
- (2013) Louis G. Chicoine et al. MOLECULAR THERAPY
- Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
- (2013) LG Chicoine et al. MOLECULAR THERAPY
- Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
- (2013) Dominik F. Aschauer et al. PLoS One
- Hybrid Adeno-Associated Viral Vectors Utilizing Transposase-Mediated Somatic Integration for Stable Transgene Expression in Human Cells
- (2013) Wenli Zhang et al. PLoS One
- Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
- (2013) F. Mingozzi et al. Science Translational Medicine
- AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy
- (2012) Brian Bostick et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy
- (2012) Jong-Hee Kim et al. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
- Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping
- (2012) Adeline Vulin et al. MOLECULAR THERAPY
- The AAV Vector Toolkit: Poised at the Clinical Crossroads
- (2012) Aravind Asokan et al. MOLECULAR THERAPY
- Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo
- (2011) J D White et al. GENE THERAPY
- TerminalN-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
- (2011) Shen Shen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up
- (2011) Francesca Magri et al. JOURNAL OF NEUROLOGY
- Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
- (2011) Steven J Gray et al. MOLECULAR THERAPY
- AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
- (2011) Brian Bostick et al. MOLECULAR THERAPY
- Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins
- (2011) Amit C Nathwani et al. MOLECULAR THERAPY
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
- (2011) Dawn E Bowles et al. MOLECULAR THERAPY
- Human Hepatocyte Growth Factor Receptor Is a Cellular Coreceptor for Adeno-Associated Virus Serotype 3
- (2010) Chen Ling et al. HUMAN GENE THERAPY
- Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs
- (2010) Joe N Kornegay et al. MOLECULAR THERAPY
- Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6
- (2010) Melodie L Weller et al. NATURE MEDICINE
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice
- (2009) Maria Grazia Di Certo et al. HUMAN MOLECULAR GENETICS
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
- (2009) Sandra Duque et al. MOLECULAR THERAPY
- Persistent Expression of FLAG-tagged Micro dystrophin in Nonhuman Primates Following Intramuscular and Vascular Delivery
- (2009) Louise R Rodino-Klapac et al. MOLECULAR THERAPY
- Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
- (2009) J. Kota et al. Science Translational Medicine
- Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
- (2008) G. P. Niemeyer et al. BLOOD
- A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in Dogs
- (2008) Yongping Yue et al. MOLECULAR THERAPY
- Microutrophin Delivery Through rAAV6 Increases Lifespan and Improves Muscle Function in Dystrophic Dystrophin/Utrophin-deficient Mice
- (2008) Guy L Odom et al. MOLECULAR THERAPY
- Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic mdx Mice
- (2008) Paul Gregorevic et al. MOLECULAR THERAPY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy
- (2008) Douglas P Millay et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now